journal article·2024-10Open access

Multi‐Metallic Nanosheets Reshaping Immunosuppressive Tumor Microenvironment through Augmenting cGAS‐STING Innate Activation and Adaptive Immune Responses for Cancer Immunotherapy

Yuxuan Peng, Shuang Liang, Dan Liu, Kongshuo Ma, Kaiqing Yun, Mengli Zhou, Linna Hai, Mengdi Xu, Yiyang Chen, Zhaohui Wang

Advanced Science· Volume 11· Issue 38

Abstract

Abstract The highly immunosuppressive tumor microenvironment (TME) restricts the efficient activation of immune responses. To restore the surveillance of the immune system for robust activation, vast efforts are devoted to normalizing the TME. Here, a manganese‐doped layered double hydroxide (Mn‐LDH) is developed for potent anti‐tumor immunity by reversing TME. Mn‐LDH is synthesized via a one‐step hydrothermal method. In addition to the inherent proton neutralization capacity of LDH, the introduction of manganese oxide endows LDH with an additional ability to produce oxygen. Mn‐LDH effectively releases Mn2+ and Mg2+ upon exposure to TME with high levels of H+ and H2O2, which activates synthase‐stimulator of interferon genes pathway and maintains the cytotoxicity of CD8+ T cells respectively, achieving a cascade‐like role in innate and adaptive immunity. The locally administered Mn‐LDH facilitated a “hot” network consisting of mature dendritic cells, M1‐phenotype macrophages, as well as cytotoxic and helper T cells, significantly inhibiting the growth of primary and distal tumors. Moreover, the photothermal conversion capacity of Mn‐LDH sparks more robust therapeutic effects in large established tumor models with a single administration and irradiation. Overall, this study guides the rational design of TME‐modulating immunotherapeutics for robust immune activation, providing a clinical candidate for next‐generation cancer immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: interferon and immune responses · Immune cells in cancer · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100050 China

Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100050 China

Funding

Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China · Chinese Academy of Medical Sciences

References (45)

Show source-provided references
1. 10.1126/scitranslmed.aar191610.1126/scitranslmed.aar1916 ↗
2. 10.1038/s41571-019-0308-z10.1038/s41571-019-0308-z ↗
3. 10.3389/fimmu.2023.113330810.3389/fimmu.2023.1133308 ↗
4. 10.1038/nm.339410.1038/nm.3394 ↗
5. 10.1038/s12276-023-01114-w10.1038/s12276-023-01114-w ↗
6. 10.1016/j.bbadis.2004.08.00310.1016/j.bbadis.2004.08.003 ↗
7. 10.20892/j.issn.2095-3941.2020.010610.20892/j.issn.2095-3941.2020.0106 ↗
8. 10.1002/advs.20220493210.1002/advs.202204932 ↗
9. 10.1038/s44222-022-00004-610.1038/s44222-022-00004-6 ↗
10. 10.3389/fimmu.2021.74130510.3389/fimmu.2021.741305 ↗
11. 10.1186/s12951-022-01661-w10.1186/s12951-022-01661-w ↗
12. 10.1016/j.cell.2021.12.03910.1016/j.cell.2021.12.039 ↗
13. 10.1002/adma.20220691510.1002/adma.202206915 ↗
14. 10.1002/anie.20231853010.1002/anie.202318530 ↗
15. 10.1038/cr.2009.13910.1038/cr.2009.139 ↗
16. 10.1073/pnas.221427811910.1073/pnas.2214278119 ↗
17. 10.1038/s41577-021-00524-z10.1038/s41577-021-00524-z ↗
18. 10.1016/j.immuni.2014.10.01710.1016/j.immuni.2014.10.017 ↗
19. 10.1016/j.cell.2021.09.01910.1016/j.cell.2021.09.019 ↗
20. 10.1186/s12967-023-04446-310.1186/s12967-023-04446-3 ↗
21. 10.1016/j.immuni.2018.03.01710.1016/j.immuni.2018.03.017 ↗
22. 10.1002/adma.20230484510.1002/adma.202304845 ↗
23. 10.1021/acsnano.5b0677910.1021/acsnano.5b06779 ↗
24. 10.1002/adhm.20220228010.1002/adhm.202202280 ↗
25. 10.1038/nri.2017.14510.1038/nri.2017.145 ↗
26. 10.1016/j.clay.2017.12.02110.1016/j.clay.2017.12.021 ↗
27. 10.1002/advs.20210383610.1002/advs.202103836 ↗
28. 10.1039/D1NJ02513A10.1039/D1NJ02513A ↗
29. 10.1039/D2NR05449C10.1039/D2NR05449C ↗
30. 10.1002/adfm.20221336410.1002/adfm.202213364 ↗
31. 10.7150/thno.3698810.7150/thno.36988 ↗
32. 10.3390/molecules2714463810.3390/molecules27144638 ↗
33. 10.1038/nri392110.1038/nri3921 ↗
34. 10.1038/s41577-021-00524-z10.1038/s41577-021-00524-z ↗
35. 10.1038/ni.355810.1038/ni.3558 ↗
36. 10.1038/ncomms1168610.1038/ncomms11686 ↗
37. 10.1021/acs.nanolett.3c0294110.1021/acs.nanolett.3c02941 ↗
38. 10.1016/j.isci.2020.10153010.1016/j.isci.2020.101530 ↗
39. 10.1016/j.jconrel.2023.01.04310.1016/j.jconrel.2023.01.043 ↗
40. 10.1038/s41467-020-19540-z10.1038/s41467-020-19540-z ↗
41. 10.1038/s12276-023-01105-x10.1038/s12276-023-01105-x ↗
42. 10.1002/adfm.20190706610.1002/adfm.201907066 ↗
43. 10.1016/j.ijbiomac.2023.12436210.1016/j.ijbiomac.2023.124362 ↗
44. 10.1038/s41467-019-12771-910.1038/s41467-019-12771-9 ↗
45. 10.1016/j.nantod.2023.10178210.1016/j.nantod.2023.101782 ↗